Life Sciences and Healthcare companies are all undergoing some form of seismic transformation.  As we near the end of the COVID19 pandemic, health sciences organizations are forced to adapt to the new normal. Life sciences companies have adapted to pandemic accelerated innovation developing and distributing vaccines in record time while managing the supply of medicines across borders, workforce safety, and handle evolving government restrictions.  Life sciences companies have also moved from a “blockbuster focus to patient centric” while evolving their supply chains, adapting to new government regulations and becoming more transparent to their ecosystem.

The healthcare industry is also experiencing disruption like we have never seen. Healthcare payers are struggling with accelerating digital transformation, effectively adopting various “cloud first” strategies and execution plans, winning the war for scarce talent, managing through evolving regulatory requirements, innovating to meet the needs of evolving members all while fending off future challenges from hyperscalers and other disruptors.  Healthcare providers have these challenges and more including increased cost pressures and evolving demographics poised to embrace telemedicine, internet of medical things and other emerging trends.    
ISG’s own Jenn Stein and Bob Krohn will discuss the state of the healthcare and life sciences industries today and reveal their predictions for the future.